Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CLX | Common Stock | Award | $26.2K | +171 | $153.11 | 171 | Mar 28, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CLX | Deferred Stock Units | Award | $0 | +61.4 | +0.78% | $0.00 | 7.9K | Feb 9, 2024 | Common Stock | 61.4 | Direct | F2, F3, F4 |
Id | Content |
---|---|
F1 | Receipt of Common Stock in lieu of quarterly director's fee. |
F2 | 1-for-1 |
F3 | Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. |
F4 | The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |